Table 1.
Descriptive statistics regarding basal comorbid conditions and associated asthma features in the studied population (n = 133).
| Moderate Asthma | Severe Asthma | |
|---|---|---|
| n = 133 | 71 (53.38%) | 62 (46.62%) |
| Age (y.o.) | 29.59 ± 13.82 | 33.85 ± 16.05 |
| <20 y.o. (n = 41) | 19 ± 7.3 (26.76%) | 16 ± 5.21 (25.8%) |
| >20 y.o. (n = 92) | 52 (73.24%) | 46 (74.2%) |
| Sex (F/M) | 56.33%/43.67% | 61.3%/38.7% |
| BMI | 26.54 ± 5.9 | 28.59 ± 5.4 |
| Allergic Rhinitis | 64 (90.14%) | 55 (88.7%) |
| Atopic Dermatitis * | 17 (23.94%) | 4 (6.45%) |
| Nasal Polyposis * | 2 (2.81%) | 8 (12.9%) |
| Food Allergy | 9 (12.67%) | 3 (4.83%) |
| NSAID sensitivity | 2 (2.81%) | 2 |
| ACT | 18 (16–25) | 14 (9–17) |
| FVC | 3728 (90.1 ± 13.56%) | 3212 (79.0 ± 15.03%) |
| FVC < 20 y.o. | 90.87 ± 15.67% | 81.24 ± 17.22% |
| FEV1 * | 3027 (91.32 ± 15.07%) | 2475 (76.12 ± 17.41%) |
| FEV1 < 20 y.o. | 92.33 ± 18.81% | 81.92 ± 16.33% |
| SPT+HDM/SM | 71 (100%) | 62 (100%) |
| Total IgE (IU/mL) | 635 ± 733 | 661 ± 702 |
| Eosinophils/μL peripheral blood * | 395 ± 225 | 420 ± 259 |
| Asthma Onset at Childhood | 53 (74.6%) | 48 (77.41%) |
| Family History of Atopy | 59 (83.09%) | 51 (82.25%) |
SPT: Skin Prick Test. SM: Storage mites. BMI: Body Mass Index. ACT: Asthma Control Test. FVC: Forced Ventilatory Capacity. FEV1: forced expiratory volume in the first second. Median values and standard error of the median (SEM) are shown. * Indicates statistical significance (p < 0.05).